Adherence to Brazilian HIV-AIDS treatment guidelines: A 3-year retrospective analysis of dispensing data

Página do item simplificado
dc.creatorCassia Cristina Pinto Mendicino
dc.creatorLeticia Penna Braga
dc.creatorLeonardo Vinicius Dias da Silva
dc.creatorMenezes de Padua
dc.date.accessioned2022-10-18T22:28:55Z
dc.date.accessioned2025-09-08T23:55:44Z
dc.date.available2022-10-18T22:28:55Z
dc.date.issued2017-08-22
dc.format.mimetypepdf
dc.identifier.doihttps://doi.org/10.1002/pds.4275
dc.identifier.issn1099-1557
dc.identifier.urihttps://hdl.handle.net/1843/46344
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management
dc.rightsAcesso Aberto
dc.subjectHIV
dc.subjectAIDS
dc.subjectTratamento
dc.subject.otherHIV
dc.subject.otherAIDS
dc.subject.otherTratamento
dc.titleAdherence to Brazilian HIV-AIDS treatment guidelines: A 3-year retrospective analysis of dispensing data
dc.typeArtigo de evento
local.citation.epage344
local.citation.issue33
local.citation.spage343
local.description.resumoBackground: Brazilian HIV/AIDS therapeutic guidelines are reviewed regularly to provide updated guidance on antiretroviral treatment of people living with HIV. Antiretroviral regimens are highly effective for managing disease and preventing HIV dissemination. Thus, to evaluate the appropriateness of their use is crucial. Objectives: Describe the profile of dispensing of antiretroviral regimens and the adherence to Brazilian therapeutic guidelines for HIV treatment in adults. Methods: Retrospective analysis of dispensing data of antiretroviral drugs from HIV/AIDS public referral centres in Minas Gerais state, Brazil. Data from the Medication Logistics Control System from 2014 to 2016 were reviewed. Antiretroviral regimens were classified into five categories according to 2014/2015 Brazilian guidelines: first line regimen – FLR, second line regimen – SLR, salvage therapy – ST, other regimens – OR and non-recommended regimen – NRR. Results: A total of 917,754 antiretroviral regimens (equivalent to 696 different combinations and 42,302 patients) were dispensed: 60.3% FLR, 16.9% SLR, 3.2% ST, 19.3% OR and 0.3% NRR, being FLR, SLR and ST in accordance with the guidelines. FLR and SLR included most frequently combinations of tenofovir (or zidovudine) + lamivudine + efavirenz (90.1%), and tenofovir (or zidovudine) + lamivudine + boosted-atazanavir (87.1%), respectively. Raltegravir and boosted-darunavir were the most frequent drugs used in ST (89.3%). Roughly 67% (193/289 combinations) of the OR comprised tenofovir (or zidovudine) + lamivudine + unboosted-lovinapir combinations. NRR included tenofovir + didanosine associations (43.6%), which could lead to pancreatitis and lactic acidosis. Virologic effectiveness of darunavir- or saquinavirbased regimens would be prevented in 22.6% of NRR as these antiretroviral drugs were contained in unboosted preparations. Conclusions: While demonstrating high agreement with the national guidelines, the findings also showed a considerable rate of OR and NNR. This highlights the need for increased vigilance of dispensing of antiretroviral drugs in order to provide better clinical outcomes.
local.publisher.countryBrasil
local.publisher.departmentFAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS
local.publisher.initialsUFMG
local.url.externahttps://onlinelibrary.wiley.com/doi/full/10.1002/pds.4275

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
Adherence to Brazilian HIV-AIDS Treatment Guidelines A 3-Year Retrospective Analysis of Dispensing Data.pdf
Tamanho:
69.19 KB
Formato:
Adobe Portable Document Format
Baixar

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
2.07 KB
Formato:
Plain Text
Descrição:
Baixar

Coleções

Artigo de Evento

Logo UFMG